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Abstract
The Use of Broadband  Incoherent Infrared Radiation (SSIR System) for the 
Treatment of  Non-Infectious Disorders
Research on the treatment of various chronic  conditions with broad band 
infrared radiation was begun in the late 1980's at St. Petersburg, Russia, after 
successful development of special silicon diodes with  relatively high output 
intensities. Diodes in current use have output throughout the range of 3,000 to 
60,000 nanometers with total output power of 2 - 3 watts. About one-half of the 
output is below  25,000 nm and one-half above 25,000 nm with broad peaks 
between 22,000  and 32, 000 nm and between 45,000 and 57,000 nm. Conditions 
which have been successfully treated in clinical trials include Benign Prostate 
Hyperplasia,  burns, Carpal Tunnel Syndrome, diabetes,  osteoarthritis, periodontal 
disease, surgical wounds,  and  stomach and duodenal ulcers. Anecdotal incidents 
suggest that  the radiation may be effective in the treatment of  cancer 
chemotherapy side effects, drug withdrawal symptoms,  gall bladder attacks, gout, 
muscle fatigue, pancreatitis, and warts. There is evidence that  irradiation increases 
oxygen delivery to the tissues. Irradiation of the blood stream during open heart 
surgery stabilizes lactate and increases Heat Shock Protein 72. 
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USA
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The Use of Broadband  Incoherent Infrared Radiation (SSIR System) for the 
Treatment of  Non-Infectious Disorders
Introduction
The SSIR System uses broadband infrared radiation to treat a variety of non-infectious 
disorders. The spectral distribution of the radiation, produced by a special silicon diode,  lies 
between 3,000 and 60,000 nanometers. (Figure 1) Typical input power  is 2 - 4 watts. Input 
power is adjusted to produce a standard output    radiation power, estimated at  about 500 milli-
watts.  Normal aperture diameter is 30 mm, producing radiation intensity of  70 mW/cm2 . A 
typical treatment session duration is 20 minutes, so energy applied to site is 84 joules/cm2. A 
typical series of treatments is 20 minutes per day for 10 days.
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Spectral Distribution of SSIR Radiation
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Spectral Distribution of Infrared Heat Lamp Radiation
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Figure 1.Comparison of Spectral Distributions of SSIR output  with Infrared Heat Lamp Output
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There are two adaptations of the SSIR System.  In one the silicon diode is housed in a 
module similar to a wrist watch.  The module is held in contact with the skin at the treatment site 
with a Velcro strap or adhesive tape.  In the other the silicon diode is mounted in a conical 
reflector.  Mounting hardware similar to a desk lamp is used to position the reflector over the 
treatment site.  ( Figure 2.).
Figure 2. Two Versions of SSIR System Devices
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Disorders Successfully Treated
Proven by Clinical Trials.
• Osteoarthritis of:
Fingers
Knee
            Elbow
Shoulder
Hip
• Carpal Tunnel Syndrome
• Early Parkinsonism
• Ehlers Danlos syndrome
• Elbow Crepitant Tendovaginitis
• Benign Prostate Hyperplasia
• Burn skin grafts
• Diabetes, Types I & II
• Facial surgical wounds
• Periodontal disease
• Stomach/duodenal ulcers
Anecdotal Indications.
• Osteoarthritis of:
Spine
Ankle
Toes
• Burns, direct treatment
• Cancer Chemotherapy Side 
Effects
• Gall Bladder Attacks
• Drug  Withdrawal Symptoms
• Gout
• Muscle Fatigue
• Pancreatitis
• Postural hypotension
• Prostatitis, Acute and  Chronic
• Warts
• Wounds, General
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Carpal Tunnel Syndrome (CTS)
In three  controlled clinical trials in St. Petersburg, Russia, all 52 carpal tunnel syndrome patients 
realized significant reduction in the severity of symptoms. Some received total relief of symptoms. In a trial 
at Robertsdale, Alabama, clinical trial data show a reduction or resolution in the severity of CTS symptoms 
in 8 of 9 participants and an improvement in functional status in 8 out of 9.  (See Tables 1a., 1b. and 1c.)  
Table 1a.  Reduction in Severity of CTS Symptoms – St. Petersburg, Russia
CTS Severity Impairment Score
Before Treatment After Treatment
Score Patients
Patients
Very Mild
(20 -  25)
Patients
Mild
(26 -  35)
Patients
Moderate
(36 - 54)
Patients
Severe
(55 - 71)
Patients
Very Severe
(71 - 90)
Moderate           (36 - 54) 20 15 5 0 0 0
Severe                (55 - 71) 25 4 9 12 0 0
Very severe       (72 - 90) 7 3 2 2 0 0
Table 1b. – Reduction in Severity of CTS Symptoms – Robertsdale, AL  
Patients CTS Severity Impairment Score
Before Treatment After Treatment
Score Patients
Patients
None
(11 - 22)
Patients
Mild
(23 -  33)
Patients
Moderate
(34 - 44)
Patients
Severe
(45 - 55)
Patients
Very Severe
( > 55)
Mild                 (23 - 33) 2 1 1 0 0 0
Moderate         (34 - 44) 7 2 5 0 0 0
Table 1c. – Improvement in Functional Status.
CTS Functional Status Score
Before Treatment After Treatment
Score Patients Patients
No 
Difficulty
(8 - 15)
Patients
Mild 
Difficulty
(16 -  23)
Patients
Moderate 
Difficulty
(24 -  31)
Patients
Severe
Difficulty
(32 -39)
Patients
Unable to
 Perform
(40 - >)
Mild Difficulty             
(16 - 23)
7 6 1 0 0 0
Moderate Difficulty
 (24 - 31)
1 0 1 0 0 0
Severe Difficulty         
(32 - 39)
1 0 1 0 0 0
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Osteoarthritis (OA) of Fingers, Hip, Knee, Elbow, and Shoulder.
Clinical trial data collected on a total of 40 patients with erosive interphalangeal, scaphometacarpal, 
rheumatoid finger (remission stage), or post traumatic finger arthritis show average reduction in joint elastic 
stiffness of 53 % (range: 35 - 66, standard deviation: 7)   and increase in relative joint range of motion of 49 
% (range: 6 - 105, standard deviation: 28).   Clinical trial data collected on a total of 60 knee patients with 
knee OA: medial, patellofemoral, and lateral compartments, rheumatoid (remission stage), or post traumatic   
show average reduction in joint elastic stiffness of 43 % (range: 30 - 55, standard deviation: 9); average 
improvement in relative joint range of motion of 12 % (range: -3 - +42, standard deviation: 9). Elastic 
stiffness and range of motion were measured with an electro-mechanical device. (See Table 2.)
Table 2.  Improvement in Joint Elastic Stiffness and Range of Motion by Treatment of Osteoarthritis 
of the Fingers and Knees, Early Parkinsonism, and Ehlers-Danlos Syndrome with Incoherent Infrared 
Radiation (SSIR)
Diagnosis Subjects Per Cent Change
Elastic Stiffness Relative Range of Motion
Average Range Standard 
Deviation
Average Range Standard 
Deviation
Finger-OA 40 53 35 - 66 7 49 6 - 105 28
EIA 10 59 54 - 62 2 75 50 - 95 12
S 10 58 50 - 66 6 47 30 - 62 12
RA(F) 10 47 37 - 57 8 12 6 - 18 4
PTA(F) 10 48 35 - 57 8 61 30 - 105 26
Knee-OA 60 43 30 - 55 9 12 -3 - 42 9
MC 8 57 47 - 68 6 16 8 - 34 10
LC 7 49 42 - 56 4 22 16 - 42 8
PC 7 41 31 - 49 6 24 16 - 42 9
RA(K) 8 37 33 - 43 4 13 8 - 24 6
PTA(K) 30 41 30 - 55 7 5 -3 - 18 4
Metabolic
EP 10 39 2 - 52 10 21 10-42 11
ED* 10 47 19 - 95 23 9 -9 - 20 8
EIA - Erosive Interphalangeal Arthritis                                                S - Scaphometacarpal arthritis            
RA(F) - Rheumatoid Finger Arthritis  (remission stage)                       PTA(F) - Post Traumatic Finger  
Arthritis               
MC, LC, PC - Medial, Lateral, Pattelofemoral Compartment (knee) 
RA(K) – Rheumatoid Knee Arthritis (remission stage)                        PTA(K) – Post Traumatic Knee 
Arthritis
EP - Early Parkinsonism                                                               ED* - Ehlers-Danlos Syndrome (negative 
values)
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Clinical trial data collected on a total of 20 patients each with hip, elbow, or shoulder OA is shown in Table 3. Results were scored by the 
patient for joint pain, joint stiffness, physical function, and global assessment (general condition) using a standard questionnaire developed and 
validated for use in OA drug trials. A composite total score was obtained by adding scores for individual parameters. All patients showed 
improvement in one or more parameters and in global assessment, although the results varied widely among parameters and among patients. 
Total scores correlated well with the patient's global assessment.
Elbow Crepitant Tendovaginitis
Clinical data collected on a total of 20 patients with elbow crepitant tendovaginitis, also collected using a patient questionnaire, is shown 
in Table 3. All patients reported significant improvement in all categories, pain, stiffness, physical functions, and global assessment.
Table 3.  Improvement in Symptoms of Osteoarthritis of Hip, Elbow, and Shoulder and Elbow Crepitant Tendovaginitis by Treatment 
with Incoherent Infrared Radiation (SSIR)
Diagnosis Subjects Per Cent Change
Pain Stiffness Physical Function Global Assessment
Total
Avg Range SD Avg Range SD Avg Range SD Avg Range SD Avg Range SD
OA-Hip 20 58 14 - 86 24 81 8 - 83 21 39 12 - 75 20 52 11 - 87 25 31 13 - 17 20
OA-Elb 20 61 31 - 80 12 44 2 - 73 16 53 14 - 75 14 65 24 - 94 15 56 20 - 78 12
OA-Sh 20 61 19 - 94 18 46 19 - 81 15 56 9 - 85 19 54 6 - 97 27 58 20 - 89 18
ECTV 20 63 24 - 93 18 59 26 - 95 19 56 19 - 84 17 65 20 - 88 18 58 21 - 86 17
OA-Hip - Osteoarthritis of Hip OA-Elb - Osteoarthritis of  Elbow   OA-Sh - Osteoarthritis of  Shoulder
ECTV - Elbow Crepitant Tendovaginitis    Avg - Average SD - Standard Deviation
9
Table 4.  Improvement in Joint Elastic Stiffness and Range of Motion by Treatment of Osteoarthritis of the Fingers and Knees, Ehlers-Danlos Syndrome, and Early Parkinsonism 
with Incoherent Infrared Radiation (SSIR) Retained after Six and Twelve Months
Diagnosis Subjects Per Cent Change Capillary Oxygen Partial Pressure
Elastic Stiffness Range of Motion Per Cent Change
Treatment 6 months 12 months Treatment 6 months 12 months
Before
Treatment
Treatment 6 months 12 months
Avg Rng Avg Rng Avg Rng Avg Rng Avg Rng Avg Rng Avg Rng Avg Rng Avg Rng Avg Rng
EIA 3 58 54-61 53 52-54 51 49-54 78 76-80 67 61-71 64 52-71 4 3-5 211 200-233 139 125-160 128 100-160
S 3 61 58-66 55 53-57 53 52-57 54 48-62 45 40-54 41 30-52 4 3-5 246 220-267 163 133-180 145 100-175
RA(F)* 3 47 45-49 43 39-46 42 42-43 12 8-17 9 6-14 9 5-13 3 2-4 261 200-350 172 150-200 125 100-150
PTA(F) 3 48 42-57 42 39-46 41 39-42 58 30-98 48 22-76 43 23-62 4 3-5 222 200-267 139 125-160 109 67-160
MC* 3 60 56-68 51 50-52 48 44-51 18 8-26 7 -1-18 8 4-12 2 2-3 339 267-400 189 150-250 183 167-200
LC 3 48 41-56 39 34-42 36 32-40 21 16-23 12 7-19 10 4-15 3 2-3 322 267-400 178 133-200 139 67-200
PC 3 40 36-43 33 25-38 32 23-37 27 16-42 18 10-31 13 6-23 2 2-3 394 333-450 256 200-300 194 150-233
RA(K)* 3 39 34-43 34 28-41 36 32-40 9 8-10 5 5-6 4 3-6 2 2-3 350 300-400 200 150-250 200 200-200
PTA(K) 3 42 36-46 35 32-39 33 29-38 4 3-5 1 0-3 1 0-3 2 2-3 417 400-450 294 250-333 278 250-333
EP 3 40 27-52 33 21-47 32 20-47 23 10-37 16 6-32 14 5-32 4 3-4 219 200-233 153 133-175 114 67-175
ED 3 43 25-56 35 20-47 29 16-38 6 -9-14 4 -7-10 4 -5-10 4 3-4 231 200-267 156 150-167 92 75-100
EIA - Erosive Interphalangeal Arthritis  MC, LC, PC - Medial, Lateral, Pattelofemoral Compartment (knee) 
RA(F) - Rheumatoid Finger Arthritis (remission stage)       S - Scaphometacarpal arthritis
RA(K) - Rheumatoid Knee Arthritis (remission stage)                            PTA(K) - Post Traumatic Knee  Arthritis   
EP - Early Parkinsonism                                                                         ED - Ehlers-Danlos Syndrome (negative values)  
Avg – Average                                                Rng - Range
*One of three subjects effectively re-treated  9-11 months after initial treatment.
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Benign Prostate Hyperplasia.
Clinical trial data on the treatment of benign prostate hyperplasia (BHP) with SSIR show 
some improvement in one or more parameters in nineteen of twenty subjects with improvements 
in various symptom parameters as shown in Table 5. Radiation is directed to the center of the 
perineum with the end of the reflector positioned against the skin.
Table 5.  Improvement in Benign Prostate Hyperplasia (BPH) Symptom Parameters by 
Treatment with Incoherent Infrared Radiation (SSIR)
Parameter Average % Improvement Range of % 
Improvement
Standard Deviation
BPH Index 33 0 - 70 29
Urination Rate 20 0 - 67 16
Prostate Rel. Vol. 21 0 - 37 11
Doppler Flow 60 0 - 100 42
Leucocytes 43 2 - 69 20
Lecithin Grains 35 0 - 100 26
Prostatic Secretion pH 7 0 - 12 4
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Burn Skin Grafts.
A total of 20 patients with facial or neck burns covering an area equal to 1-2 % of the body were treated 
with SSIR radiation, beginning the second day after the burn. Skin grafts after pre-treatment with SSIR were 
successful in all of the cases. The state of the blood circulation in the damaged area was measured by rheography 
with the results shown in Table 6. All indices were returned to normal or near normal by treatment with SSIR.
   Table 6.   Improvement in Blood Circulation Parameters by Treatment of Burns with SSIR Radiation
Before treatment After 1st  session After 10th session
#
Diagnosis RI IVT PR RI IVT IPR RI IVT IPR
 1. II degree burn on the left parotid area 0.05 21 90 0.06 20 86 0.08 17 77
2. IIIA degree burn on  left cheek and nose-lip 
fold
0.03 24 95 0.05 21 90 0.07 18 81
3. II degree burn on the parietal area 0.04 22 91 0.06 20 85 0.09 16 76
4. II degree burn on  left auricle and side of  
neck
0.05 21 89 0.07 21 83 0.08 18 72
5. II degree burn on the chin and lower lip 0.05 24 92 0.06 23 88 0.07 18 80
6. II degree burn on the forehead 0.04 23 88 0.06 21 81 0.07 17 77
7. IIIA degree burn on the right parotid area 0.04 26 96 0.06 24 91 0.08 19 79
8. II degree burn on the chin 0.05 21 91 0.07 19 85 0.08 15 80
9. II degree burn on the forehead and nose 0.04 24 89 0.06 22 80 0.07 18 73
10. IIIA degree burn on  right cheek and nose-
lip fold
0.03 28 92 0.05 25 86 0.07 19 77
11. IIIA degree burn on the chin and lower lip   0.03 25 93 0.06 22 88 0.07 17 79
12. II degree burn on the left cheek and parotid 
area
0.06 21 87 0.07 18 80 0.09 15 75
13. II degree burn on the chin 0.05 23 86 0.05 22 79 0.07 18 72
14. IIIA degree burn on  right auricle and side 
of  neck
0.04 27 90 0.06 24 84 0.08 18 75
15. II degree burn on the forehead 0.03 20 89 0.04 18 81 0.06 15 77
16. II degree burn on the right cheek 0.05 23 92 0.06 19 88 0.07 16 80
17. IIIA degree burn on the parietal area 0.04 26 97 0.06 22 91 0.08 17 82
18. II degree burn on the parotid area 0.03 22 89 0.04 19 86 0.07 17 79
19. II degree burn on the chin 0.04 24 91 0.06 21 85 0.09 18 79
20. II degree burn on  right cheek and nose-lip 
fold
0.05 21 90 0.07 19 84 0.10 16 78
AVERAGES
STANDARD DEVIATIONS
0.042
±0.0087
23.3
±2.19
90.85
±2.76
0.0585
±0.0085
21.0
±1.97
85.05
±3.54
0.077
±0.0095
17.1
±1.22
77.4
±2.8
   Notes to tables:  (1) RI = rheographic index (0.07 - 0.09 is normal);    (2) IVT = index of tonic vascular tension 
(15 - 18 % is normal);   (3) IPR = index of peripheral vascular resistance (70 - 80 % is normal).  
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Diabetes, Types I and II.
A large number of diabetes patients with both types I and II have been clinically treated successfully.  
In an initial study 100 patients suffering from types I and II diabetic angiopathy syndrome of the extremities 
received four consecutive daily treatments of 15 minutes each. Sessions were divided equally between the 
region of the lower back over the left and right kidneys. Increases in blood flow in the big toe occurred with 
temperature increases ranging from   0.9 to 1.5 degrees C. Significant reduction in pain and also a feeling of 
warmth was reported after the first treatment. Before treatment the rate of blood flow correlated positively 
with glucose and immunoreactive insulin. After treatment there was a positive correlation with concentration 
of MDA in the blood. (Table 7)   Stabilization of blood pressure occurred in some patients with 
hypertension. 
A controlled clinical trial involving 7 patients with diabetes and 5 with no disease conditions 
confirmed the original results.  Table 8 shows the outcomes measured by a four-level sensory response 
questionnaire, local blood circulation and skin temperature of the feet. On average about 60 % of the increase 
in blood flow and temperature were retained one month later.
In another trial using 100 subjects relief of symptoms of angiopathy syndrome of the extremities was 
realized without recurrence within one year on 70 of the patients. The 30 patients with unsuccessful 
treatment had less than normal stomach acidity. Success of this group was increased by treatment with 
therapeutic iron and zinc compounds. In most cases SSIR radiation treatment of diabetes should be 
complemented with iron and zinc supplements.
TABLE 7.  EFFECT OF INCOHERENT INFRARED RADIATION (SSIR) ON BLOOD FLOW AND 
RELATED PARAMETERS IN TREATMENT OF DIABETIC ANGIOPATHY OF THE 
EXTREMITIES.
Before IR 
Treatment
After IR 
Treatment
Correlation Coefficient with Blood 
Volume per Minute
Before After
Stroke volume 78.4  ± 2.3 93.3 ± 6.0
Glucose 10.6 ± 2.5 8.7 ± 2.4 0.86 0.41
Insulin 8.6 ± 2.3 13.4 ± 3.1 0.74 0.37
MDA 4.2 ± 3.1 5.1 ± 2.1 0.33 0.74
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      Table 8. Improvement in Diabetes I and II by Treatment with Incoherent Infrared Radiation (SSIR)
Existence of Pain in Muscles and Joints
Without 
Movement
With Movement
Cold(-) or Warm(+)
 in Extremities
Bloodflow  in Extrem-
ities
(Conv. Units)
Skin Temp.  Rad. Site
Deg. C
Skin Temp. Feet
Deg. C.
# Diagnosis
0s 1s 7s 1mo 0s 1s 7s 1mo 0s 1s 7s
1 
mo
0s 1s 7s 1 mo 0s 1s 7s
1 
mo
0s 1s 7s
1 
mo
1
Diabetes I 
Intermed. Sev.
- - - - +++ + - -
--
-
+ +++ ++ 44 62 68 54 36.1 37.4 37.0 36.2 35.2 36.4 36.4 36.2
2
Diabetes I 
Intermed. Sev.
+ - - - ++++ ++ + -
--
-
+ ++ ++ 36 51 58 49 35.9 37.4 37.6 36.1 35.4 36.1 36.7 36.0
3
Diabetes II
Mild Sev.
- - - - ++ - - -
--
-
+ ++ + 41 74 67 59 35.8 37.7 37.5 36.3 35.3 37.1 36.4 36.2
4
Diabetes II
Intermed. Sev.
++ + - + +++ + - +
--
-
+ +++ + 37 67 74 61 35.6 36.8 37.1 36.2 35.1 36.4 36.3 35.9
5
Diabetes I 
Intermed. Sev.
+ - - - ++ - - -
--
-
- ++ ++ 51 84 81 76 36.5 36.9 37.1 36.2 35.2 35.9 36.1 35.4
6
Diabetes I 
Intermed.Sev.
- - -- - ++ - -- --
--
-
+ +++ ++ 58 87 83 64 36.0 37.6 36.1 35.9 35.2 37.4 37.1 36.1
7
Diabetes II
Intermed. 
Seve
+ -- -- -- +++ +
--
-
-
--
-
+ + + 35 48 54 47 35.9 37.2 37.4 36.1 35.4 36.1 36.2 35.9
                              Averages for Group of Diabetic Patients 43 67 69 59 35.9 37.2 37.4 36.1 35.3 36.4 36.2 35.9
#                                                           Healthy Men Ages 17 – 21 Years
1 + ++ +++ + 67 84 84 71 36.0 37.4 37.2 36.1 36.0 36.7 36.5 36.6
2 + ++ +++ + 68 93 95 69 36.1 37.5 37.1 36.2 35.8 36.5 36.6 36.1
3 + +++ +++ + 71 91 92 74 36.4 37.6 37.5 35.9 36.2 36.4 36.3 36.3
4 + ++ +++ + 65 86 93 68 36.5 37.8 37.4 36.0 36.1 36.5 36.4 36.0
5 + ++ +++ + 74 89 94 73 36.0 37.6 37.3 35.8 36.2 36.4 36.4 36.2
                                                  Averages for Control Group 69 89 92 71 36.2 37.6 37.3 36.0 36.0 36.5 36.4 36.2
    Notes to Tables:
(1) + means subject has symptom, number of +s is extent measured with a four-level questionnaire.
(2) – signifies absence of symptom or reduction in symptom, number of –s indicates extent of reduction.
(3) 0s is before treatment; 1s after 1 treatment; 7s after 7 treatments; 1 mo is 1 month after last treatment
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A clinical trial involving 16 subjects with mild to moderate Type II diabetes, as indicated by 
initial levels of Random Plasma Glucose in the range of  11.1 to 22.2 mmol/L (200 - 400 mg/DL) 
and HbA1c in the range of 6.6 to 8.0 %, were treated with SSIR radiation for 10 minutes  per day 
at each of two sites on either side of the lower back and 2 sites on either side of the middle 
abdomen Monday through Friday for 8 weeks. Table 9 shows the outcome measured by change 
in Random Plasma Glucose and change in HbA1c. All 16 patients showed improvement in both 
outcome measures. 8 of 16 reached the level of Random Plasma Glucose for non-diabetics. 14 of 
16 reached American Diabetes Association HbA1c goal for diabetics of  7% or below. 9 of 16 
reached American Association of Clinical Endocrinology goal of 6.5% or below. Results suggest 
that additional improvement may be realized  with treatments extending beyond 8 weeks. 
Table 9. Improvement in Random Plasma Glucose and HbA1c in Type II
 Diabetes Patients by Treatment with Incoherent Infrared Radiation (SSIR)
Before treatment After 4 weeks After 8 weeksPatient
Glucose level
mmol/L
HbA1c
%
Glucose level
mmol/L
HbA1
%
Glucose level
mmol/L
HbA1c
%
1 13.2 7.0 11.8 6.5 10.9 6.2
2 12.1 6.8 11.7 6.6 11.5 6.5
3 17.4 7.5 13.4 6.9 11.8 6.6
4 14.7 7.2 12.3 6.8 11.1 6.5
5 16.3 7.4 12.7 6.9 10.8 6.6
6 18.5 7.6 14.1 7.1 12.0 6.9
7 11.5 6.6 10.8 6.2 9.9 6.0
8 19.1 7.8 15.8 7.3 13.1 6.9
9 18.7 7.7 16.3 7.5 14.8 7.4
10 15.6 7.3 12.6 6.8 11.9 6.5
11 13.9 7.0 11.9 6.5 10.4 6.3
12 12.6 6.9 11.2 6.6 10.5 6.4
13 18.1 7.5 14.8 6.9 12.1 6.7
14 20.8 8.0 16.3 7.5 14.2 7.1
15 11.9 6.7 11.0 6.3 10.1 6.1
16 12.4 6.9 10.3 6.4 9.8 6.0
Note: Glucose level is Random Plasma Glucose
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Facial Surgery Wounds.
A total of 30 patients undergoing various facial surgeries were treated with SSIR radiation of the wound and facial artery in consecutive daily sessions of 
10 minutes each. Results were evaluated by observing edema and measuring vascular parameters by rheovasography. Reduction of pain and disappearance of 
edema were noted after the first session. The appearance of the scar is less pronounced than expected in the normal case. This should be of particular interest to 
cosmetic plastic surgeons. All parameters had become normal after six sessions. (See Table 10.)
TABLE 10.  Improvement in Healing of Facial Surgery Wounds by Treatment with Incoherent Infrared Radiation (SSIR)
After surgery After  1st session After  6th session
# Diagnosis ed PB VWR IVT ed PB VWR IVT ed PB VWR IVT
1. Deformation scar on the upper lip after cleft corrective surgery + 100 79 91 - 118 88 82 - 127 93 71
2. Deformation of the nose tip after nasal split corrective surgery + 100 80 88 - 115 91 80 - 128 96 69
3. Deformation scar after the trauma of parotid area + 100 82 87 - 122 92 79 - 135 97 68
4. Deformation scar on the upper lip after cleft corrective surgery + 100 78 90 - 117 87 79 - 126 92 69
5. Deformation scar on the forehead after trauma + 100 77 92 - 125 87 81 - 131 93 72
6. Contracting scar on the upper lip + 100 81 89 - 121 90 78 - 130 94 67
7. Deformation scar on the chin area after the burn + 100 83 92 - 118 92 80 - 131 96 71
8. Deformation of the nose tip after the nasal split corrective surgery + 100 81 91 - 123 92 77 - 128 95 68
9. Deformation of the nose tip after nasal split corrective surgery + 100 79 90 - 114 90 79 - 125 94 72
10. Deformation scar on the upper lip after cleft corrective surgery + 100 80 92 - 126 89 81 - 134 94 73
11. Deformation scar on the forehead area after  trauma + 100 78 89 - 119 89 80 - 130 93 70
12. Contracting scar on the upper lip + 100 77 88 - 120 88 77 - 131 93 66
13. Deformation scar on the upper lip after cleft corrective surgery + 100 82 86 - 117 91 75 - 126 96 65
14. Deformation scar on the upper lip after cleft corrective surgery + 100 79 89 - 122 92 78 - 129 97 70
15. Deformation of the nose tip after nasal split corrective surgery + 100 83 89 - 121 93 81 - 130 98 74
16. Deformation scar on the forehead area after  trauma + 100 81 90 - 116 90 79 - 127 95 68
17. Deformation scar on the chin after trauma + 100 80 87 - 120 91 76 - 129 95 67
18. Contracting scar on the upper lip + 100 82 89 - 123 90 78 - 133 96 68
19. Deformation of the nose tip after nasal split corrective surgery + 100 78 92 - 118 89 81 - 132 94 70
20. Deformation scar on the upper lip after cleft corrective surgery + 100 77 90 - 124 88 81 - 135 94 71
21. Deformation scar on the upper lip after cleft corrective surgery + 100 81 91 - 121 92 79 - 129 98 68
22. Deformation scar on the parotid area after trauma + 100 79 87 - 122 90 78 - 131 95 69
23. Contracting scar on the upper lip + 100 78 90 - 118 89 79 - 126 94 68
24. Deformation scar on the right cheek after  trauma + 100 83 92 - 119 93 81 - 125 98 71
25. Contracting scar on the upper lip + 100 80 89 - 123 91 80 - 132 95 70
26. Deformation of the nose tip after nasal split corrective surgery + 100 81 87 - 119 90 79 - 130 96 69
27. Deformation of the nose tip after nasal split corrective surgery + 100 79 86 - 120 91 75 - 131 95 65
28. Deformation scar on the upper lip after cleft corrective surgery + 100 78 88 - 124 89 77 - 135 94 67
29. Deformation scar on the nose and cheek after trauma + 100 82 91 - 121 90 82 - 129 95 70
30. Deformation of the nose tip after nasal split corrective surgery + 100 79 92 - 117 91 83 - 130 96 71
AVERAGES
STANDARD DEVIATION
+ 100 79.9
±1.8
89.47
±1.87 -
120.1
±2.9
90.17
±1.62
79.17
±1.98 -
129.83
±2.83
95.03
±1.56
69.23
±2.17
Notes to table: (1) ed = edema;       (2) PB = Pulse blood filling (results obtained after surgery taken as 100);       (3) VWR = reduction in vascular walls resistance (normal is 95 
or greater);       (4) IVT = index of tonic vascular tension (normal is lower than 70)
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Peridontal Disease.
SSIR radiation has been used clinically at the Stomatological Clinic of the First St. Petersburg 
Medical Institute (Russia) for treating paradontosis and paradontitis. Results of treatment of 14 patients in a 
clinical trial are shown in Table 11. Bleeding, edema, and hyperesthesia were eliminated with 5 consecutive 
daily sessions of ten minutes each. Peripheral resistance and muscle tone as determined by rheodontographic 
analysis were returned to near normal in all cases. Change in amplitude and smoothing of the peaks and 
valleys of the rheodontographs indicate increase in flexibility of the walls of the blood vessels after 
treatment. (Figure 3.)
SSIR is also used to reduce pain and hasten healing after shred surgery for severe cases. Pain 
disappears after the first session. Healing proceeds without complications and the time required is reduced by 
1-2 days. 
In patients with alveolitis and pain in the gum cavity following tooth extraction, pain is reduced after 
2-3 sessions; disappears after 5 sessions.
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Table 11. Results of the Treatment of Paradontosis and Paradontitis with SSIR
# Diagnosis Before Treatment After Treatment
Bl. Ed. Hyp. IH RI IPR
(%)
IVT
(%)
Bl. Ed. Hyp. HI RI IPR
(%)
IVT
(%)
1 General Paradontitis
Intermediate Severity
+ + + 1.3 .11 90 30.5 - - - 1.1 .1 70 15
2 " + + + 1.4 .21 65 12.5 - - - 1.0 .1 70 15
3 " + + - 1.3 .07 40 40 - - - 1.0 .09 75 16
4 General Paradontosis
Initial Stage
+ + - 1.2 .11 29 10 - - - 1.0 .1 70 15
5 General Paradontosis Developing 
Stage Intermediate Severity
+ + + 1.4 .22 93 20 - - - 1.1 .09 90 14
6 " + + ± 1.2 .12 92 31 - - - 1.0 .08 75 16
7 Paradontitis - - + 1.1 .20 93 17 - - - 1.1 .09 85 15
8 " - - + 1.2 .11 94 16 - - - 1.0 .08 84 14
9 General Paradontitis
Initial Stage
+ ± - 1.3 .12 65 12 - - - 1.1 .09 75 13
10 " + ± - 1.3 .11 93 17 - - - 1.0 .08 85 14
11 " + - - 1.4 .12 65 13.5 - - - 1.0 .09 72 13
12 General Paradontitis Developing 
Stage Intermediate Severity
+ + + 1.3 .13 92 28 - - - 1.0 .1 70 15
13 General Paradontitis
Initial Stage
+ - - 1.4 .10 68 12.5 - - - 1.0 .1 74 14
14 General Paradontitis Developing 
Stage Mild Severity
+ - - 1.3 .07 70 12 - - - 1.0 .08 75 13
Average for Patients No 1,5,6,7,8,10,12 1.26 .143 92.4 22.8 1.04 .09 79.9 14.7
Average for Patients No 2,4,9,11,13 1.34 .133 58.4 12.1 1.02 .096 72.2 14.0
Notes to Table:  (1) General paradontitis - peridontose with inflammation stretching over all the teeth.  (2) Hyperesthesia - excessive 
sensitivity of naked tooth neck and root.
 (3) Index of Dental Hygiene - (IH) - according to the method of Fedrov & Volodkina (in healthy persons 1.0) (larger the number, the                   
                                        poorer the hygiene)
 (4) Indices calculated from rheoparadontographic data.    (RI), rheographic index (0.07 - 0.09 is normal).    (IPR), index of peripheral  resistance (70 - 90 % is normal); if IPR 
is more than 90%, patient has constriction and spasm of blood vessels, e.g. in  arteriosclerosis, if IPR is less than 70% there is dilatation of blood vessels.  (IVT), index 
of muscle tone (13 - l5% is normal).
(5) + indicates presence or increase; - indicates absence or decrease. BL = bleeding  ED = edema  HYP = hyperesthesia
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Figure 3. Rheodontographs Before and After Treatment with SSIR Radiation
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Stomach /Duodenal Ulcers.
A total of 340 patients with uncomplicated and chronic gastric or duodenal ulcers have been 
treated in clinical trials with SSIR radiation. The ulcer was located with an endoscope and the 
radiation directed over the site, using 20-minute sessions at one or two day intervals. Pain was 
eliminated in 1-4 sessions, with cure, determined endoscopically, realized in 2 - 9 sessions. There 
were no recurrences within one year after treatment.
Anecdotal Indications.
Osteoarthritis:
Ankle.
Osteoarthritis (OA) of the ankle along with that of other joints has been treated routinely 
at an arthritis clinic in St. Petersburg, Russia, with success equal to that shown in clinical trials 
on other joints.
Toes.
A patient in the United States who was treating OA of the First CMC joint and who also had 
OA in her toes realized  relief  in the feet while irradiating the thumb before relief at the 
treatment site.
Spine.
Two patients in the United States with acute and chronic OA of the spine have received 
complete relief of symptoms. One with a severe acute case centered at the eighth vertebra was 
given a series of 10 treatments with nearly complete elimination of symptoms. After waiting one 
week he received another series of 10 treatments, with total relief after the fifth treatment. He 
completed the second 10 treatment series in May, 1998. By October, 2001   no symptoms had 
reappeared.
It is to be expected that osteoarthritis of any joint in the human body may respond to SSIR 
treatment. The poorest candidate seems to be the hip. Response is not universal but it appears 
that failures are generally concentrated in those joints in which all or nearly all of the cartilage 
has degenerated.
Burns, Direct Treatment.
People in the United States who have had access to an instrument have been prone to treat a 
variety of conditions which occur. One person received immediate relief of pain and diminishing 
of blood vessel proliferation, and ultimate healing of a burn on the hand which was becoming 
steadily worse. He also received immediate relief of sunburn pain without normal blistering. 
Two patients received relief of pain on fingers which touched a hot object within 4 minutes after 
beginning the treatment session. Expected blistering failed to occur and pain did not return after 
treatment.
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Postural Hypotension.
A one hundred year old woman was trying the radiation on a line of tumors formed along the 
incision line of an earlier breast excision. She had been suffering spells of hypotension when 
arising at night to use the bathroom. After a few treatments with SSIR near her heart she noticed 
the postural hypotension incidents no longer occurred. It was later determined that she had a 
partially blocked aorta.
Pancreatitis.
Heavy drinking of alcohol is endemic in Russia, leading to many incidents of pancreatitis. 
Immediate relief of pain and subsequent elimination of inflammation has been achieved with 
SSIR irradiation.
Gall Bladder Attacks.
One woman who is subject to frequent gall bladder attacks gets immediate relief of pain 
without recurrence during that attack after irradiating with SSIR. Radiation has reduced the 
frequency of attacks.
Acute and Chronic Prostatitis.
A 71 year old patient whose prostate biopsy indicated minor acute and chronic prostatitis was 
advised to have Prostate Specific Antigen complex test at 6 month intervals. He has had a series 
of  SSIR prostate radiation treatments between each test interval. No increase in Benign Prostate 
Hyperplasia symptoms have occurred after one year and the PSA level has remained constant, 
suggesting the prostatitis has been arrested.
Cancer Chemotherapy Side Effects.
One middle aged woman undergoing chemotherapy in 1999 treated herself with SSIR 
radiation to the lower back. The side effects of the chemotherapy were not as intense as 
expected.
General Wound Healing.
Many wounds have been treated with SSIR radiation but without controlled studies. More 
rapid healing than expected is generally reported. Some wounds which had been particularly 
resistant to healing have undergone normal healing after treatment.
Muscle Fatigue.
Persons who are subject to several episodes of muscle cramp during the night after strenuous 
exercise and loss of electrolyte have reported that SSIR irradiation of the normally affected 
muscle along with oral electrolyte replacement eliminates or reduces the number and severity of 
the episodes. Competitive bicyclists have reported rapid recovery of muscles after treating with 
SSIR radiation. 
Gout.
One person has successfully treated gout by irradiation of the affected foot.
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Drug Withdrawal Symptoms
Russian physicians have reported relief of drug withdrawal symptoms by treatment with 
SSIR radiation during drug rehabilitation.
Open Heart Surgery
The external bloodstream was irradiated with SSIR radiation during open heart surgery in 
a series of operations. Recovery time was reduced and success rate increased. Lactic acid was 
stabilized and there was an increase in Heat Shock  Protein 72.
Mechanism Hypothesis 
In the studies with outcomes reported in Table 4 above, the partial pressure of capillary 
oxygen (PPO) was measured before treatment, after treatment, after 6 months and after one year 
with a very precise transcutaneous oximeter. For purposes of analysis a related study determined 
PPO for healthy persons in a range of ages with results shown in Table 12.  As expected normal 
levels of transcutaneous oxygen decreased slightly with age. When this data is compared with 
the same data for osteoarthitic joints before treatment, immediately after a treatment series, six 
months later, and one year later it is clear that there is a severe oxygen deficiency at 
osteoarthritic joints (average healthy 13; arthritic 3) .This is largely eliminated by SSIR treatment 
(average healthy 13; treated 12).  It is evident that the treatment with SSIR has restored oxygen 
to oxygen deficient tissue. This allows tissue regeneration where that process has been curtailed. 
The tissue regeneration also occurs in walls of blood vessels, restoring flexibility and providing 
increased blood delivery of nutrients. Evidence for this was shown in the studies of treatment of 
periodontal diseases with changes in the amplitude and smoothing of peaks and valleys of the 
rheodontographs. It was shown in the treatment of facial surgical wounds with index of 
peripheral resistance returning to normal. It was shown in the treatment of diabetes with 
measured increases in blood flow in the feet bringing about increases in skin temperature. For 
every condition that has been treated effectively it can be reasonably concluded that the results 
are realized by improvement in localized metabolism  All results of treatment of every condition 
are consistent with improved tissue regeneration associated with increased oxygenation and the 
corresponding improvement in local metabolism. In some cases, for example increases in insulin 
after irradiating the pancreas, this may be regeneration of organ tissue and restored function of 
the organ. In osteoarthritis improvement in joint stiffness and range of motion may occur through 
cartilage regeneration.  Reduction in inflammation and a corresponding diminishment of pain 
may be related to increases in the rate of healing brought about with increase in oxygen and 
blood nutrients delivery.
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Table  12.  Age Related Transcutaneous Oxygen Partial Pressure (PPO) in Healthy Joints 
Compared with PPO of Osteoarthritic Joints Before Treatment, After Treatment, Six Months After 
Treatment and One Year After Treatment. 
Age Group PPO Average Standard Deviation
31-40 15 14.6 0.58
15
14
15
14
41-50 13 13.6 0.55
14
14
14
13
51-60 13 12.6 0.55
12
13
12
13
61-70 12 11.6 0.55
11
11
12
12
Healthy (31-70) 20 13.1 1.25
Before Treatment 33 3.1 1.0
After Treatment 33 11.6 1.9
6 Month After 33 8.7 2.7
1 Year After 30 8.0 2.7
